Navigation Links
Jubilant Enters Research Collaboration With AstraZeneca
Date:5/5/2009

NOIDA, India, May 5 /PRNewswire/ --

- Research Collaboration to Provide AstraZeneca With New Preclinical Drug Candidates

Jubilant Organosys Ltd, headquartered in India, announced today that its Bangalore, India, based subsidiary,Jubilant Biosys Ltd, has signed a research collaboration agreement with, AstraZeneca, and focused on delivering novel drug candidates into the international pharmaceutical company's pre-clinical pipeline. Under the shared risk-reward collaboration, which will initially focus on the neuroscience area, Jubilant aims to deliver a steady stream of discovery programs to AstraZeneca.

AstraZeneca will own the compounds developed under the collaboration with worldwide development and commercialization rights. Jubilant will be eligible to receive research funding spanning an initial five-year period. In addition, AstraZeneca will also pay Jubilant success-based development milestones, as well as royalties based on successful global commercialization of any of the compounds.

Commenting on this Collaboration, Mr. Shyam S Bhartia, Chairman & Managing Director and

Mr. Hari S Bhartia, Co-Chairman & Managing Director, Jubilant Organosys Ltd, said: "We are very pleased to partner with AstraZeneca, this collaboration will leverage the innovative capabilities of AstraZeneca and Jubilant Biosys in providing a robust global drug discovery model. Through this partnership, Jubilant is confident of contributing to AstraZeneca's preclinical portfolio and anticipates significant rewards from successful downstream milestones. This partnership furthers Jubilant's strategy to be India's largest provider of innovative and integrated pharmaceutical solutions, enabling the global pharmaceutical industry's quest to discover affordable innovative medicines."

Jan Lundberg, Executive Vice-President, Global Discovery, at AstraZeneca says, "This collabor
'/>"/>

SOURCE Jubilant Organosys Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NovaBay(R) Pharmaceuticals Enters into Agreement to Broaden Intellectual Property Estate and Expand Clinical Opportunities for Its Aganocide(R) Compounds
2. Elusys Anthrax Anti-Toxin, Anthim(TM), Enters Second Phase I Clinical Study
3. Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)
4. Another LNA-based RNA Inhibitor Enters Clinical Trials
5. Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study
6. ESBATechs Antibody Fragment Enters Phase Ib/IIa in Ophthalmology
7. ESBATechs Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity
8. ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers
9. PreMD Inc. Enters Clinical Study with Cosmetics Conglomerate
10. CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
11. Pharmaleads Lead Candidate for Pain, PL37, Enters Phase I
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... YORK , July 3, 2015  Obsidian HDS, ... - an online service for the management of data ... announced today that PharmaShine now includes the 2014 Open ... for Medicare Services on June 30. The data disclosed ... million transactions between industry and providers totaling $6.49 billion ...
(Date:7/2/2015)... Pharma Major Lupin Limited ... en ZAO "Biocom" en Rusia bajo ciertas condiciones ... Lupin en el mercado farmacéutico de Rusia que ... como uno de los 10 principales mercados farmacéuticos ... de una década, el mercado farmacéutico ruso registró ...
(Date:7/2/2015)... , July 2, 2015 Leading ... to capture critical product and market insights in ... benefits to employee-based studies, it is essential for ... own internal employees to capture critical business-related insights. ... benchmarking firm, Best Practices, LLC, most benchmarked companies ...
Breaking Medicine Technology:New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3Leveraging Employee Insights to Produce Cutting-Edge Market Research 2
... Systems, Inc. (OTCBB: OXYS) ("OxySure"), the pioneering manufacturer ... "oxygen from powder" technology has announced the Company ... W.W. Grainger, Inc. (NYSE: GWW ) ... In terms of the Agreement, OxySure will ...
... GREENWICH, Conn., March 15, 2012 Timothy C. Tyson, ... has been named President and Chief Operating Officer of ... Clinical Trials Supply Business, Mr. Needleman has been promoted ... Operations. In his new role, Mr. Needleman is responsible ...
Cached Medicine Technology:OxySure Systems Announces Supplier Agreement With Grainger 2OxySure Systems Announces Supplier Agreement With Grainger 3Aptuit LLC Names Stuart E. Needleman as President and Chief Operating Officer 2
(Date:7/3/2015)... ... ... " Selfie on a Stick ” was featured on NewsWatch as part ... to consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted the ... , Almost every smartphone has an incredibly powerful camera built into it. And when ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the opening ... located in the Lone Star State. The premium frozen yogurt chain was listed as #22 ... opened June 19 in the Village at Bachman Lake, is located at:, 3701 W. Northwest ...
(Date:7/2/2015)... ... July 02, 2015 , ... Many Fourth of July celebrations will ... Amica Insurance is sharing some tips to promote the proper use of ... go to the emergency room daily with fireworks-related injuries in the month surrounding the ...
(Date:7/2/2015)... ... July 02, 2015 , ... Get ready ... SIGVARIS PERFORMANCE SOCKS. Since the socks were first introduced, they have rapidly been ... popularity has inspired four new, fun shades including: blue, lime, pink and red. ...
(Date:7/2/2015)... N.J. (PRWEB) , ... July 02, 2015 , ... ... ACO and Emerging Healthcare Delivery Coalition met for the late June Web-based session, ... forward with new reimbursement schemes and managing high-risk patients through coordinated care. , ...
Breaking Medicine News(10 mins):Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 2Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 4
... persons in the Shangdong province of eastern China have been ... has since been contained, state news agency Xinhua has ... last and another 393 people mostly children were ... the agency said, citing Bao Wenhui, the deputy director of ...
... do not completely control epilepsy, surgery often can, and the ... epilepsy specialists are struggling to get that message to tens ... knife at younger ages. ,Says Dr. Deborah Holder, ... be thought of as a last resort. Now we don't ...
... found that the male impotence drug Viagra may be ... originally developed for the treatment of high blood pressure ... reduces levels of a naturally-occurring compound, cyclic guanine monophosphate ... vital function in a signalling pathway that regulates the ...
... concentrated radio waves appears to be a safe and effective ... that can be a precursor of cancer . ... esophagus, a condition associated with the continued reflux of stomach ... over time. While this condition is relatively common, a small ...
... to completely wipe out wild relatives of plants such as ... by the Consultative Group on International Agricultural Research (CGIAR). ... as many as 61 percent of the 51 wild peanut ... species analyzed could become extinct as the result of climate ...
... respond favorably to the drug temozolomide when used as ... to work best in people missing a certain gene. ... the American Academy of Neurology. ,Researchers studied ... of brain tumor, who were treated with temozolomide chemotherapy ...
Cached Medicine News:Health News:Potential Of Epilepsy Surgeries Are Not Fully Harnessed Say Brain Specialists 2Health News:New Approach to Treating Precancerous Esophagus Condition 2Health News:New Approach to Treating Precancerous Esophagus Condition 3Health News:Climate Change Threatening to Wipe Out Wild Relatives of Key Crops 2
... Professional Diagnostics is a leading provider of ... DFA test menu that includes kits for ... well as miscellaneous conjugates and components. Our ... wide assortment of substrates and kit sizes ...
... Professional Diagnostics is a leading provider of ... DFA test menu that includes kits for ... well as miscellaneous conjugates and components. Our ... wide assortment of substrates and kit sizes ...
... Inverness Medical Professional Diagnostics is a ... extensive IFA and DFA test menu that ... and STDs as well as miscellaneous conjugates ... give you a wide assortment of substrates ...
... Professional Diagnostics is a leading provider of ... DFA test menu that includes kits for ... well as miscellaneous conjugates and components. Our ... wide assortment of substrates and kit sizes ...
Medicine Products: